CID 133000

Embusartan

Structural Information

Molecular Formula
C25H24FN5O3
SMILES
CCCCC1=CC(=CC(=O)N1CC2=C(C=C(C=C2)C3=CC=CC=C3C4=NNN=N4)F)C(=O)OC
InChI
InChI=1S/C25H24FN5O3/c1-3-4-7-19-12-18(25(33)34-2)14-23(32)31(19)15-17-11-10-16(13-22(17)26)20-8-5-6-9-21(20)24-27-29-30-28-24/h5-6,8-14H,3-4,7,15H2,1-2H3,(H,27,28,29,30)
InChIKey
LYVGOAYMIAQLHI-UHFFFAOYSA-N
Compound name
methyl 2-butyl-1-[[2-fluoro-4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-6-oxopyridine-4-carboxylate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

9
References

2489
Patents

461.1863 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 462.19358 213.1
[M+Na]+ 484.17552 221.7
[M-H]- 460.17902 217.6
[M+NH4]+ 479.22012 215.2
[M+K]+ 500.14946 212.8
[M+H-H2O]+ 444.18356 198.7
[M+HCOO]- 506.18450 227.0
[M+CH3COO]- 520.20015 219.7
[M+Na-2H]- 482.16097 210.5
[M]+ 461.18575 215.1
[M]- 461.18685 215.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe